Further studies are warranted to fully understand the molecular mechanisms underlying the relationship between Wnt3a, the Wnt/β-catenin pathway, and SARS-CoV-2 infection, which could potentially lead to the development of novel therapeutics for COVID-19. The gene discussed is WNT3A; the disease is COVID-19.